Sir, We wish to comment on the article by McKinlay and Farquhar (1976) and to give the opinion of the International Study Group of Diabetes in Children and Adolescents-the association of paediatric diabetologists. At the meeting of the study group held in Belgium [25] [26] June 1976, one of the sessions was entitled 'Standardization of types of insulins and syringes' (moderator, Prof. 0. Aagenaes, Oslo).
Of course, the dual U-40/U-80 syringe is a source of dosage errors and the type of syringe with 2 graduated scales has to be discarded (Emould et al., 1973; Rosenbloom, 1974; Shainfeld, 1975) . The use of U-100 insulins is certainly of great interest for diabetic adolescents and adults who need a larger number of units each day. But in children receiving small doses of insulin, the stuay group preferred the U-40 insulins because of greater accuracy in measuring the dose in the syringe, since a smaller concentration of insulin per ml allows easier reading of graduations on the syringe.
So paediatric diabetologists of the study group would like to maintain, in Europe, the existence of U-40 insulins for diabetic children. The ideal syringe must be graduated at 1-U increments, with graduations not too close, for only a single strength of insulin, and with no dead space (Shainfeld, 1975 The insulin market has become as complex as the baby food one and is a sight more dangerous. If all currently available insulins have to exist in 2-3 concentrations in packets gay as coloured bunting at a regatta, some children will suffer, sometimes permanently, and the very real anxieties of their parents will continue. The exact concentration may matter more to manufacturers than to physicians. For the sake of diabetic children, their parents, nurses, and doctors, let us agree with industry on one concentration (U-50?) for all diabetics and on standardized syringes for all. If we compromised on U-50 in Europe and U-100 in North America the same standardized syringe could be used for both (50 graduations in 1 ml) or at least life would be less confusing for those whose diabetic practice is North Atlantic in outlook.
J (Archives, 1976, 51, 517) . They suggest that the greater proportion of breast-fed babies observed to have reducing substances in their stools may be related to the higher concentration of lactose in breast milk. In fact, the formula (prepacked half-cream Cow and Gate) given to the bottle-fed babies did not contain less lactose than human milk (7X1 g/100 ml).
We have recently analysed specimens of stools from 78 normal term neonates ranging in age from 2 to 15
